The pioneer factors FoxA1 and GATA2 are recruited to a significant portion of AR-binding sites in prostate cancer cells, facilitating AR binding to AREs by interacting directly with AR and consequently enhancing AR-mediated transcription. The gene discussed is GATA2; the disease is prostate cancer.